MARKET

HROW

HROW

Harrow Health Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.16
+0.16
+2.29%
Closed 16:00 01/22 EST
OPEN
7.03
PREV CLOSE
7.00
HIGH
7.25
LOW
7.01
VOLUME
156.17K
TURNOVER
--
52 WEEK HIGH
8.99
52 WEEK LOW
4.100
MARKET CAP
180.21M
P/E (TTM)
15.50
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HROW and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HROW News

  • Is Harrow Health, Inc. (HROW) A Good Stock To Buy?
  • Insider Monkey.12/16/2019 12:35
  • The Harrow Health (NASDAQ:HROW) Share Price Is Up 256% And Shareholders Are Boasting About It
  • Simply Wall St..12/12/2019 12:40
  • Inventor Of "LessDrops," Surgical Eyedrop, Wins Return Of Patent From Harrow Health
  • PR Newswire.12/11/2019 00:40
  • ImprimisRxs FDA-Registered Outsourcing Facility Issued California License
  • GlobeNewswire.12/10/2019 12:30

More

Industry

Biotechnology & Medical Research
+0.13%
Pharmaceuticals & Medical Research
-0.23%

Hot Stocks

Name
Price
%Change

About HROW

Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., owns diversified portfolio of healthcare businesses. The Company’s subsidiaries are Imprimis Pharmaceuticals Inc. and Park Compounding. Imprimis Pharmaceuticals Inc. is engaged in ophthalmology pharmaceutical compounding business. Park Compounding is engaged in compounding business and also offers strategic research and development facilities, which is engaged in developing and dispensing medicines for individual patients.
More

Webull offers Harrow Health Inc (HROW) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.